Stryker Corporation $SYK Shares Acquired by Sei Investments Co.

Sei Investments Co. lifted its stake in shares of Stryker Corporation (NYSE:SYK) by 1.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 427,634 shares of the medical technology company’s stock after purchasing an additional 7,655 shares during the period. Sei Investments Co. owned about 0.11% of Stryker worth $158,090,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in Stryker by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,773,399 shares of the medical technology company’s stock worth $12,485,012,000 after buying an additional 272,828 shares during the last quarter. State Street Corp raised its holdings in shares of Stryker by 1.0% during the second quarter. State Street Corp now owns 14,956,732 shares of the medical technology company’s stock valued at $5,929,765,000 after acquiring an additional 150,204 shares during the last quarter. Alliancebernstein L.P. lifted its position in shares of Stryker by 307.6% in the second quarter. Alliancebernstein L.P. now owns 5,596,508 shares of the medical technology company’s stock valued at $2,214,146,000 after acquiring an additional 4,223,366 shares in the last quarter. Norges Bank acquired a new stake in shares of Stryker in the second quarter worth approximately $1,882,173,000. Finally, Legal & General Group Plc boosted its stake in shares of Stryker by 4.4% in the third quarter. Legal & General Group Plc now owns 2,303,290 shares of the medical technology company’s stock worth $851,457,000 after acquiring an additional 96,662 shares during the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the transaction, the director directly owned 2,457,331 shares in the company, valued at $891,814,566.52. The trade was a 9.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 5.90% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on SYK shares. Piper Sandler reissued an “overweight” rating on shares of Stryker in a research note on Tuesday, January 27th. Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a report on Saturday, February 21st. Royal Bank Of Canada reiterated an “outperform” rating and issued a $435.00 target price on shares of Stryker in a research report on Friday, November 14th. Needham & Company LLC boosted their price target on shares of Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Finally, BTIG Research upped their price objective on shares of Stryker from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Fourteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and an average price target of $428.61.

More Stryker News

Here are the key news stories impacting Stryker this week:

• Positive Sentiment: Citi/analysts flag potential upside beyond the immediate disruption, suggesting a “90‑day catalyst” window where recovery or additional clarity could present buying opportunities. Cyberattack Knocks Stryker Stock (SYK) — But Citi Sees Upside with ‘90-Day Catalyst Watch’
• Neutral Sentiment: Stryker confirmed it identified a cybersecurity incident disrupting global IT/Micro‑services and is investigating; the company is communicating with customers and assessing operational impact (statement ongoing). Stryker Reports Cybersecurity Incident Disrupting Global IT Systems
• Negative Sentiment: Reuters reports the outage is causing widespread disruption to Stryker’s business operations, including the ability to process orders, manufacture products and ship to customers — a direct revenue and supply‑chain hit until systems are restored. Stryker flags disruption to orders, manufacturing a day after cyberattack
• Negative Sentiment: Multiple outlets report an Iran‑linked group (Handala) claimed a destructive wiper attack, alleging ~200,000 devices wiped and ~50TB of data seized — escalation that raises risks of prolonged outages, data breach costs and regulatory scrutiny. Stryker Cyberattack Update: Iran-Linked Handala Group Claims Destructive Wiper Attack on Medical Tech Giant
• Negative Sentiment: Market reaction: coverage shows SYK shares fell ~3–4% on initial reports as investors priced in operational disruption and uncertainty; trading volume has been above average. Stryker (SYK) Stock Plunges 3.6% Following Major Cyberattack Claim by Iran-Linked Hackers

Stryker Stock Down 2.5%

Shares of NYSE:SYK opened at $337.23 on Friday. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The business has a fifty day moving average of $365.42 and a two-hundred day moving average of $368.08. The stock has a market cap of $129.05 billion, a P/E ratio of 40.15, a PEG ratio of 2.02 and a beta of 0.85. Stryker Corporation has a 52-week low of $328.23 and a 52-week high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping the consensus estimate of $4.40 by $0.07. The business had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The company’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.01 EPS. On average, research analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.0%. Stryker’s payout ratio is 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.